ClinConnect ClinConnect Logo
Search / Trial NCT06879665

TANDem-2: Closing the Gap to Interventions for TAND

Launched by VRIJE UNIVERSITEIT BRUSSEL · Mar 13, 2025

Trial Information

Current as of May 09, 2025

Not yet recruiting

Keywords

Caregiver Well Being Psychological Flexibility Acceptance And Commitment Therapy (Act) Tuberous Sclerosis Complex (Tsc) Tsc Associated Neuropsychiatric Disorders (Tand)

ClinConnect Summary

The TANDem-2 trial is a study designed to help adult caregivers of individuals with Tuberous Sclerosis Complex (TSC), a condition that can cause various health issues. The main focus of this pilot study is to see if a short online program called "Well-Beans for Caregivers" can be easily offered to caregivers, how they feel about participating in it, and whether it makes a positive difference in their well-being.

To be eligible for this study, you need to be an adult caregiver for someone with TSC, regardless of the individual's age. The program is still in the planning stages and has not yet started recruiting participants. If you decide to join, you can expect to engage in a brief, supportive program aimed at improving your experience as a caregiver. This study is an important step in understanding how to better support caregivers like you.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adult caregiver of an individual with Tuberous Sclerosis Complex (TSC) of any age
  • Exclusion Criteria:
  • Not an adult caregiver of an individual with TSC

About Vrije Universiteit Brussel

The Vrije Universiteit Brussel (VUB) is a distinguished research university located in Brussels, Belgium, known for its commitment to innovative education and cutting-edge research across various disciplines. As a clinical trial sponsor, VUB actively engages in advancing medical knowledge and improving patient care through rigorous scientific investigations. The university fosters collaborations with healthcare institutions and industry partners, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements. VUB's research initiatives are driven by a multidisciplinary approach, leveraging expertise from fields such as medicine, health sciences, and biomedical engineering to address pressing health challenges and contribute to the development of novel therapies.

Locations

Patients applied

0 patients applied

Trial Officials

Anna Jansen, MD, PhD

Principal Investigator

Vrije Universiteit Brussel

Petrus J de Vries, MD PhD

Principal Investigator

University of Cape Town

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported